drugset / Trial / NCT01768520

Evaluation of the Efficacy and Safety of Entelon Tab. 150mg in Patients With Osteoarthritis of Knee

NCT01768520

Phase 3 Completed 338 enrolled Hanlim Pharm. Co., Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

This clinical trial is planned to prove Entelon tab. arm is not inferior to Celebrex cap. arm in terms of the efficacy and safety through the change of K-WOMAC's total score sum in patients with osteoarthritis of knee.

Timeline

Start
2012-07-02
Primary completion
2014-10-15
Completion
2015-05-13

Drugs

EvaluationDrugModalityDoseRoute
Comparator Celecoxib Other / unclassified 200 mg
Subject Vitis vinifera extract Unknown 150 mg

Indications